Rep. James C. Greenwood (R-Penn.), known for his hardball investigations into the healthcare industry, corporate scandals, and conflicts of interest at the National Institutes of Health (NIH), announced yesterday (July 22) that he will not seek re-election and instead will become president of a major biotechnology trade association when his term expires next January.
Greenwood has agreed to head the Biotechnology Industry Organization (BIO), a Washington-based trade group that represents more than 1000 companies around the world. As chairman of the House Energy and Commerce Subcommittee on Oversight and Investigations, Greenwood had spearheaded probes into financial consulting arrangements that many of these companies have with scientists and officials at the NIH, the Food and Drug Administration, and other agencies.
"It's not easy to walk away from being a congressman, and I probably wouldn't do it for any other organization," Greenwood told